Merck & Co. Inc.

NYSE: MRK · Real-Time Price · USD
82.74
0.03 (0.04%)
At close: Aug 14, 2025, 3:59 PM
83.39
0.79%
Pre-market: Aug 15, 2025, 07:29 AM EDT

Merck & Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
64.17B 60.12B 59.28B 48.7B
Cost of Revenue
15.19B 16.13B 17.41B 13.63B
Gross Profit
48.98B 43.99B 41.87B 35.08B
Operating Income
20.22B 2.95B 18.28B 13.2B
Interest Income
415M 365M 157M 36M
Pretax Income
19.94B 1.89B 16.44B 13.88B
Net Income
17.12B 365M 14.52B 13.05B
Selling & General & Admin
10.82B 10.5B 10.04B 9.63B
Research & Development
17.94B 30.53B 13.55B 12.24B
Other Expenses
n/a n/a n/a n/a
Operating Expenses
28.75B 41.03B 23.59B 21.88B
Interest Expense
1.27B 1.15B 962M 806M
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
43.95B 57.16B 41B 35.51B
Income Tax Expense
2.8B 1.51B 1.92B 1.52B
Shares Outstanding (Basic)
2.53B 2.61B 2.53B 2.53B
Shares Outstanding (Diluted)
2.54B 2.55B 2.54B 2.54B
EPS (Basic)
6.74 0.14 5.73 5.16
EPS (Diluted)
6.74 0.14 5.71 5.14
EBITDA
25.71B 6.91B 21.32B 17.9B
EBIT
21.21B 3.04B 17.41B 14.69B
Depreciation & Amortization
4.5B 3.87B 3.91B 3.21B